...
首页> 外文期刊>BMC Nephrology >Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort
【24h】

Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort

机译:验证中国队列对比诱导的急性肾损伤的术前风险评分

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Pre-operative risk scores are more valuable than post-procedure risk scores because of lacking effective treatment for contrast-induced acute kidney injury (CI-AKI). A number of pre-operative risk scores have been developed, but due to lack of effective external validation, most of them are also difficult to apply accurately in clinical practice. It is necessary to review and validate the published pre-operative risk scores for CI-AKI. We systematically searched PubMed and EMBASE databases for studies of CI-AKI pre-operative risk scores and assessed their calibration and discriminatory in a cohort of 2669 patients undergoing coronary angiography or percutaneous coronary intervention (PCI) from September 2007 to July 2017. The definitions of CI-AKI may affect the validation results, so three definition were included in this study, CI-AKI broad1 was defined as an increase in serum creatinine (Scr) of 44.2?μmol/L or 25%; CI-AKI broad2, an increase in Scr of 44.2?μmol/L or 50%; and CI-AKI-narrow, an increase in Scr of 44.2?μmol/L. The calibration of the model was assessed with the Hosmer-Lemeshow test and the discriminatory capacity was identified by C-statistic. Of the 8 pre-operative risk scores for CI-AKI identified, 7 were single-center study and only 1 was based on multi-center study. In addition, 7 of the scores were just validated internally and only Chen score was externally validated. In the validation cohort of 2669 patients, the incidence of CI-AKI ranged from 3.0%(Liu) to 16.4%(Chen) for these scores. Furthermore, the incidence of CI-AKI was 6.59% (178) for CI-AKI broad1, 1.44% (39) for CI-AKI broad2, and 0.67% (18) for CI-AKI-narrow. For CI-AKI broads, C-statistics varied from 0.44 to 0.57. For CI-AKI-narrow, the Maioli score had the best discrimination and calibration, what’s more, the C-statistics of Maioli, Chen, Liu and Ghani was ≥0.7. Most pre-operative risk scores were established based on single-center studies and most of them lacked external validation. For CI-AKI broads, the prediction accuracy of all risk scores was low. The Maioli score had the best discrimination and calibration, when using the CI-AKI-narrow definition.
机译:由于缺乏对造影急性肾损伤(CI-AKI)的有效治疗,术前风险评分比程序后风险分数更有价值。已经开发了许多术前风险分数,但由于缺乏有效的外部验证,大多数在临床实践中也难以准确申请。有必要审查和验证CI-AKI的已发表的术前风险分数。我们系统地搜索了PubMed和Embase数据库,以研究CI-AKI预惯例风险评分,并评估其在2007年9月至2017年7月至7月进行冠状动脉造影或经皮冠状动脉干预(PCI)的2669名患者队列中的校准和歧视。 CI-AKI可能会影响验证结果,因此本研究包含三种定义,CI-AKI宽度1被定义为血清肌酐(SCR)的增加44.2μmol/ L或25%; CI-AKI Broad2,SCR的增加44.2?μmol/ L或50%;和CI-AKI窄,SCR的增加44.2?μmol/ L.通过Hosmer-Lemeshow测试评估模型的校准,C统计学鉴定了歧视性能。在鉴定的CI-aki的8种术前风险评分中,7个是单中心研究,只有1基于多中心研究。此外,7分的分数刚刚验证,只有陈得分在外部验证。在2669名患者的验证队列中,CI-AKI的发病率从3.0%(刘)为16.4%(陈)。此外,CI-AKI的CI-AKI的发病率为CI-AKI宽的CI-AKI宽度为6.59%(178),为CI-AKI宽度为0.67%(18),用于CI-AKI窄。对于CI-AKI宽广,C统计量可达0.44至0.57。对于CI-aki-andry,Maioli评分具有最佳的歧视和校准,更重要的是,Maioli,Chen,Liu和Ghani的C统计≥0.7。基于单中心研究建立了大多数术前风险评分,其中大部分缺乏外部验证。对于CI-AKI宽广,所有风险评分的预测准确性都很低。使用CI-AKI狭窄的定义,Maioli评分具有最佳的歧视和校准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号